<p>HUVECs were transfected with siRNA targeting Akt1 (siAkt1), rictor (siRict<sup>1</sup>) or raptor (siRapt). <b>A)</b> The ECs were seeded on gelatin-coated electrodes at equal density to reach confluence. The recovery of electric impedance was measured following delivery of a high electric current through an electrode to create a defect in the EC monolayer as described in Methods. Data are represented as the relative rate of migration per hour <i>versus</i> the control (n = 3 independent experiments, *<i>P</i><0.05 by ANOVA). HUVECs were transfected with siRict<sup>1</sup>, or siAkt1, or treated with PP242. <b>B)</b> The EC were seeded equally on gelatin-coated electrodes, then adhesion was evaluated using electrical impedance measuremen...
<p>(<b>A</b>) Phalloidin detection shows cells with polarized F-actin (white arrow) following treatm...
<p><b>(A)</b> HBMECs were transfected with 50nM of either scramble or PTPN-2 siRNA. After 48 hours o...
(A) ArpC2-floxed mouse fibroblasts were treated with DMSO (ArpC2 Flox) or tamoxifen (ArpC2 KO) for 6...
<p>HUVECs plated on gelatin matrix were transfected with small interfering RNA against rictor (siRic...
<p>HUVECs were transfected with siRict<sup>1</sup> or siAkt1, then stimulated with 20 ng/mL VEGF for...
<p>(A) Phase-contrast (PhC) microscopy in cultured HUVECs at 72 h after siRNA transfection or 30 min...
<p>A: Cells were co-microinjected with siRNA mTOR, siRNA Rictor, siRNA Raptor, or control siRNA, and...
<p>(A) The cells were treated with the myr-AKT plasmid or empty vector for 48 hours in the presence ...
<p>(<b><i>A-C)</i></b> RPE cells were transfected with siRNA targeting AMPK α1/2 or non-targeting (N...
<p>(A) Immunoblotting verified the degree of transgelin 2 (TAGLN2) depletion by siRNA. β-actin was e...
<p>(<b>A</b>) Representative pictures of the NOK-SI cell scratch assay following treatment with vehi...
(A) HeLa cells were treated with control siRNAs or independent siRNAs targeting mDia1 and infected w...
<p>HPAECs were transfected with VEGFR2-specific siRNA. Control cells were treated with non-specific ...
(A) HUVECs were transfected with scrambled siRNA or striatin targeted siRNA 1, 2 or 3 for 48h. Stria...
<p>HUVECs were treated by rapamycin, two different small interfering RNAs against rictor (siRict<sup...
<p>(<b>A</b>) Phalloidin detection shows cells with polarized F-actin (white arrow) following treatm...
<p><b>(A)</b> HBMECs were transfected with 50nM of either scramble or PTPN-2 siRNA. After 48 hours o...
(A) ArpC2-floxed mouse fibroblasts were treated with DMSO (ArpC2 Flox) or tamoxifen (ArpC2 KO) for 6...
<p>HUVECs plated on gelatin matrix were transfected with small interfering RNA against rictor (siRic...
<p>HUVECs were transfected with siRict<sup>1</sup> or siAkt1, then stimulated with 20 ng/mL VEGF for...
<p>(A) Phase-contrast (PhC) microscopy in cultured HUVECs at 72 h after siRNA transfection or 30 min...
<p>A: Cells were co-microinjected with siRNA mTOR, siRNA Rictor, siRNA Raptor, or control siRNA, and...
<p>(A) The cells were treated with the myr-AKT plasmid or empty vector for 48 hours in the presence ...
<p>(<b><i>A-C)</i></b> RPE cells were transfected with siRNA targeting AMPK α1/2 or non-targeting (N...
<p>(A) Immunoblotting verified the degree of transgelin 2 (TAGLN2) depletion by siRNA. β-actin was e...
<p>(<b>A</b>) Representative pictures of the NOK-SI cell scratch assay following treatment with vehi...
(A) HeLa cells were treated with control siRNAs or independent siRNAs targeting mDia1 and infected w...
<p>HPAECs were transfected with VEGFR2-specific siRNA. Control cells were treated with non-specific ...
(A) HUVECs were transfected with scrambled siRNA or striatin targeted siRNA 1, 2 or 3 for 48h. Stria...
<p>HUVECs were treated by rapamycin, two different small interfering RNAs against rictor (siRict<sup...
<p>(<b>A</b>) Phalloidin detection shows cells with polarized F-actin (white arrow) following treatm...
<p><b>(A)</b> HBMECs were transfected with 50nM of either scramble or PTPN-2 siRNA. After 48 hours o...
(A) ArpC2-floxed mouse fibroblasts were treated with DMSO (ArpC2 Flox) or tamoxifen (ArpC2 KO) for 6...